Your browser version may not work well with NCBI's Web applications. More information here...
1: J Clin Psychopharmacol. 1989 Aug;9(4):254-9.Links

A placebo-controlled study of trazodone in bulimia nervosa.

Pope HG Jr, Keck PE Jr, McElroy SL, Hudson JI.

Epidemiology Laboratory, McLean Hospital, Belmont, Massachusetts 02178.

Forty-two women who met the new narrower criteria for bulimia nervosa of DSM-III-R completed a placebo-controlled double-blind study with trazodone. The drug proved significantly superior to placebo, both in measures of frequency of binge eating and vomiting and in the patients' subjective assessments of improvement. Trazodone produced few adverse effects.

PMID: 2671058 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Trazodone

    Trazodone is used to treat depression. Trazodone is in a class of medications called serotonin modulators. It works by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balan...

  • Source: AHFS Consumer Medication Information